Jill Hows

12.7k total citations · 2 hit papers
101 papers, 9.8k citations indexed

About

Jill Hows is a scholar working on Hematology, Immunology and Surgery. According to data from OpenAlex, Jill Hows has authored 101 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Hematology, 23 papers in Immunology and 20 papers in Surgery. Recurrent topics in Jill Hows's work include Hematopoietic Stem Cell Transplantation (66 papers), Mesenchymal stem cell research (15 papers) and Acute Myeloid Leukemia Research (14 papers). Jill Hows is often cited by papers focused on Hematopoietic Stem Cell Transplantation (66 papers), Mesenchymal stem cell research (15 papers) and Acute Myeloid Leukemia Research (14 papers). Jill Hows collaborates with scholars based in United Kingdom, Italy and France. Jill Hows's co-authors include P Beatty, Daniel Weisdorf, Klingemann Hg, Donna Przepiorka, Peyton Martin, Thomas Ed, Craig Donaldson, B. A. Bradley, P. A. Denning‐Kendall and E. C. Gordon‐Smith and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jill Hows

98 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1994 Consensus Conference on Acute GVHD Grading.

1995 4.0k citations P Beatty, Jill Hows et al. PubMed profile →
Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not

2003 532 citations Sarah Wexler, Craig Donaldson et al. British Journal of Haematology profile →

Peers

Countries citing papers authored by Jill Hows

Since Specialization

Citations

This map shows the geographic impact of Jill Hows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Hows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Hows more than expected).

Fields of papers citing papers by Jill Hows

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Hows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Hows. The network helps show where Jill Hows may publish in the future.

Co-authorship network of co-authors of Jill Hows

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Hows. A scholar is included among the top collaborators of Jill Hows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Hows. Jill Hows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy 2010 ·Annals of Hematology ·Kevin Kemp, (unknown), Sarah Wexler, Christine Cox, Elizabeth Mallam, Jill Hows, Craig Donaldson	48
2	Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA 2009 ·British Journal of Haematology ·Mark Lawler, Shaun R. McCann, Judith Marsh, Per Ljungman, Jill Hows, Elisabeth Vandenberghe, Joan O’Riordan, Anna Locasciulli, Gèrard Socié, Alan Kelly, Hubert Schrezenmeier, Pedro Marı́n, André Tichelli, Jakob Passweg, (unknown), Jacqueline Ryan, Andrea Bacigalupo, (unknown)	61
3	Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors 2006 ·Bone Marrow Transplantation ·Jill Hows, Jakob Passweg, André Tichelli, Anna Locasciulli, Richard Szydlo, Andrea Bacigalupo, (unknown), Per Ljungman, J Cornish, (unknown), Benjamin Bradley, Gèrard Socié	43
4	Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia 2006 ·Bone Marrow Transplantation ·Jakob Passweg, Waleska S. Pérez, Mary Eapen, Bruce M. Camitta, Éliane Gluckman, W Hinterberger, Jill Hows, Judith Marsh, Ricardo Pasqüini, Hubert Schrezenmeier, G. Socié, M.-J. Zhang, Christopher Bredeson	89
5	Adult stem cell therapy beyond haemopoietic stem cell transplantation? An update 2005 ·Transplant Immunology ·Jill Hows	7
6	Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia 2004 ·Transfusion ·G. J. Laundy, Benjamin Bradley, (unknown), (unknown), Jill Hows	42
7	In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells 2002 ·British Journal of Haematology ·P. A. Denning‐Kendall, Roger S. Evely, (unknown), Michael Spencer Chapman, Benjamin Bradley, Jill Hows	12
8	Current Results of Bone Marrow Transplantation in Patients with Acquired Severe Aplastic Anemia 2000 ·Acta Haematologica ·Andrea Bacigalupo, Rosi Oneto, Benedetto Bruno, Gèrard Socié, Jakob Passweg, Anna Locasciulli, M. T. Van Lint, André Tichelli, Shaun R. McCann, Judith Marsh, Per Ljungman, Jill Hows, Pedro Marı́n, Hubert Schrezenmeier	68
9	Endothelial cell precursors are normal components of human umbilical cord blood 1997 ·British Journal of Haematology ·Mie Nieda, Andrew J. Nicol, P. A. Denning‐Kendall, John Sweetenham, B. A. Bradley, Jill Hows	116
10	Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion. 1993 ·PubMed ·Jonathan Cullis, Richard Szydlo, Nicholas C.P. Cross, D I Marks, Anthony P. Schwarer, Timothy P. Hughes, Stephen Mackinnon, G Hale, Herman Waldmann, Jill Hows	8
11	Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high‐dose methylprednisolone 1993 ·British Journal of Haematology ·Judith Marsh, Athanasios Zomas, Jill Hows, (unknown), E. C. Gordon‐Smith	38
12	Bone marrow transplants using volunteer donors - Recommendations and requirements for a standardized practice throughout the world 1992 ·Bone Marrow Transplantation ·Elisa Thomas, Jon van Rood, J M Goldman, (unknown), C Raffoux, Jill Hows, N Buskard, David Shaw, K Atkinson, (unknown), P Beatty, B. A. Bradley, Éliane Gluckman, Aloïs Gratwohl, (unknown), Philip B. McGlave	19
13	Lymphocytes from multi‐transfused patients exhibit cytotoxicity against autologous cells 1992 ·British Journal of Haematology ·É. Kaminski, Jill Hows, John M. Goldman, J. R. Batchelor	15
14	Bone marrow transplantation: effects of conditioning and cyclosporin prophylaxis on microvascular permeability to a small solute (technetium 99m diethylene triamine penta-acetic acid) 1991 ·European Journal of Nuclear Medicine and Molecular Imaging ·A. M. Peters, (unknown), Jill Hows, F. W. Ballardie	6
15	UNRELATED DONOR MARROW TRANSPLANTATION BETWEEN 1977 AND 1987 AT FOUR CENTERS IN THE UNITED KINGDOM 1990 ·Transplantation ·M. R. Howard, Jill Hows, (unknown), Jennifer H. Barrett, Malcolm K. Brenner, JM Goldman, E. C. Gordon‐Smith, C Poynton, H. G. Prentice, J. A. Whittaker, Amanda J. Bradley	31
16	Long‐term follow‐up of severe aplastic anaemia patients treated with antithymocyte globulin 1989 ·British Journal of Haematology ·Mariet M. de Planque, Andrea Bacigalupo, A. Würsch, Jill Hows, Agnès Devergie, Norbert Frickhofen, Anneke Brand, C Nissen, (unknown)	162
17	Slow evolution of chronic myeloid leukaemia relapsing after BMT with T‐cell depleted donor marrow 1989 ·British Journal of Haematology ·Timothy P. Hughes, (unknown), Stephen Mackinnon, (unknown), C. Arthur, AP Guo, (unknown), Jane F. Apperley, Jill Hows, John M. Goldman	34
18	Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect 1988 ·British Journal of Haematology ·Jane F. Apperley, Francesca Romana Mauro, John M. Goldman, W. Gregory, C. Arthur, Jill Hows, William Arcese, Giuseppe Francesco Sferrazza Papa, Franco Mandelli, (unknown), P Gravett, Ian M. Franklin, Giuseppe Bandini, Paolo Ricci, S Tura, A Iacone, G Torlontano, W. Heit, Richard E. Champlin, Robert Peter Gale	152
19	Acquired factor VIII inhibitor associated with lung abscess. 1987 ·BMJ ·Peter Ganly, John D. Isaacs, Michael Laffan, Chris Haslett, Jill Hows	2
20	Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors. 1982 ·BMJ ·E. C. Gordon‐Smith, S. Fairhead, P. M. Chipping, Jill Hows, D. C. O. James, Anthony I. Dodi, (unknown)	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact